Categories: >>

Biotechnology

Updates

• Science, Intellectual Property, and Legislation in the 110th Congress
• USPTO to Re-examine Basis for Three Patents on Human Embryonic Stem Cells
• Public Patent Foundation Formally Requests Review and Revocation of Four Patents on Genetically Engineered Crops
• Patent Interference Appeals Against Biopharmaceutical Company Dropped
• GE Cotton Offers Short-term Benefits, but Unpredictable Long-term Effects
• Adoption of Patented Seeds in India Raises Questions over Preservation of Local Seed Varieties
• FDA Approves a "Biosimilar" Copy of a Biotechnology-Derived Drug
• Approval Process for Biotech-derived Generic Drugs Not Yet Established
• European Commission Remains Vague on Biotechnology Patenting; Industry Disappointed
• Emory Sells AIDS Drug Rights for Record $525 Million
• Brazil and Abbott Reach Deal on Kaletra
• ETC Reports on Impact of Nanotechnology Patents for Global South
• Supreme Court Interprets Broader Exemption for Drug Research
• WHO Holds Workshop and Open Forum on IP, Innovation and Health
• University of Pennsylvania Strategizes to Boost Tech Transfer Revenue
• WHO Studies on IP and Health Available Online
• Wellcome Trust Announces Six Month Open Access Policy
• Debate on Bioshield II Patent Provisions at Center for American Progress
• Celera Will Make DNA Information Free
• Japan Establishes High Court for IP Disputes
• Israeli Scientist's AIDS Discovery Languishes in IP Disputes
• Federal Circuit Court to Decide If Expressed Sequence Tags Are Patentable
• Merck v. Integra Briefs Available Online
• Senators Propose Patent Extensions to Spur Biodefense R&D
• Through Website, Scientists Can Tackle Companies' R&D Challenges
• Study Finds Many Human Gene Patent Claims Fall Short of Legal Standard
• EPO Upholds Revocation of Neem Patent
• Amicus Brief on Research Exemption Submitted to Supreme Court
• Proposed Medical R&D Treaty Would Provide Alternative Incentives for Innovation
• OECD Issues Draft Guidelines for Licensing Genetic Inventions
• USPTO Rejects Patent on Human-like Organism
• New Plant Biotechnology Will Be Open-Source
• Brazil Reshapes Debate on Intellectual Property
• Biodiverse Countries Ask for Treaty on Access and Benefit-Sharing
• Open Source Biology Evolves
• US Pressures Guatemala to Revise Data Protection Law
• Supreme Court Will Hear Merck v. Integra
• Digital Library to Protect Indigenous Knowledge
• Data Accessibility Must Be Improved for Systems Microbiology
• Intellectual Property Discussions Can Be Kept Secret By CA Stem Cell Agency
• World Bank Releases Two Books on IP and Development
• April 2005: WIPO Meeting on Establishing a Development Agenda
• Germany Passes New Biotech Patent Law
• NIH Requests Comments on Best Practices for Licensing Genomic Inventions
• Profits from Indigenous Knowledge Must Be Shared: Opinion – The Times of India
• WHO Initiates 23 Studies on IPRs, Innovation and Public Health
• GSK Tells Blair to Press G8 for Patent Reform
• Guatemala Repeals Data Exclusivity Rule
• IP Owners Oppose USPTO Fee Increase, Unless Profits Remain in Agency
• University of New Mexico Wins IP Dispute
• Patent Challenge Against Columbia University Dismissed
• Epogen Patent Ruling: UK Will Not Allow Overly Broad Claims
• UNEP and WIPO Release Study on Access and Benefit-Sharing
• European Commission Proposes Generic Export Regulation
• NAS Committee on IPRs in Genetic and Protein-Related Inventions: Meeting Transcript and Presentations Available
• “Innovation Sails Free”: Newsweek Article on Open Source Science
• Greenpeace Challenges Stem Cell Patent
• India Plans Policy to Attract Biotech Investors
• Malaysian State Acts to Thwart Biopirates
• UK Court Revokes Amgen Patent
• Drug Maker Promotes Generics for Workers
• Venture Capitalists Support CA Stem Cell Initiative
• Judge Rules for Amgen Patents
• Digene Settles Patent Dispute over HPV Test
• Genomics and Public Health: New Report on Science for the MDGs
• Patents in Pharmaceutical R&D: Discussion in Bulletin of the WHO
• Open Source Biotech Starts in Earnest
• Samoa to Profit from Indigenous Knowledge Deal
• Funding Pharmaceutical R&D: Alternatives to the Patent System
• Biomedical R&D Funders Requiring Collaboration
• GSK Licenses AIDS Drugs in Kenya
• The Scientist: From the Bench to the Bar
• Zambia Issues Compulsory License for AIDS Drug
• Expiring Patents Drive Drug Companies to Merge
• Pubpat Challenges Pfizer's Lipitor Patent
• China Considering Compulsory Licenses for AIDS Drugs
• Kenya Accuses U.S. Company of Biopiracy
• Chiron Settles HIV Test Patent Dispute With Roche
• Medical Journals Require Drug Trials to be Made Public
• NIH Requests Comments on Open Access Policy
• ALRC Recommends Gene Patenting Changes for Australia
• Congressman Brown Asks Thompson to Reverse NIH Norvir Decision
• Federal Stem Cell Lines Declared "Suitable" for Research
• Britain allows cloning of human cells for research
• NIH Decides Not to Intervene on Norvir Pricing
• Merck Licenses AIDS Drug to South African Generic Manufacturer
• Poor Countries Can Import Generics Without E.U. Rule
• Chinese Challenge Diabetes Drug Patent
• Open Access Language Appears in NIH Appropriations Report
• AIDS Healthcare Foundation Drops Norvir Lawsuits
• Language Barrier Slows Access to Generic Drugs
• Text of U.S. Representatives' Letter on FTAs
• Free Access to NIH-Funded Research Recommended by House Appropriations Committee
• Congress Approves Project BioShield
• Government to Open "Stem Cell Bank"
• China Overturns Viagra Patent
• Drug Companies Try to Improve Public Image
• Pfizer Expands Discount Drug Progam
• World Health Organization Proposes Global Drug Trial Registry
• Generic 3-in-1 AIDS Pill Effective in Study
• Mylan Sues FDA Over Generic Pain-Relief Patch
• Chiron Relaxes License Policy for Hepatitis C Genome
• African Agricultural Technology Foundation Opens in Kenya
• Draft text of US-Bahrain Free Trade Agreement
• Kerry Supports Further Stem Cell Research
• Singapore Boosts Intellectual Property Protection
• Open-Source Drug Discovery Proposed for Neglected Diseases
• Fifty-Eight Senators Urge Pres. Bush to Expand Stem Cell Policy
• Central American Free Trade Agreement (CAFTA) and U.S.-Bahrain FTA
• Breast Cancer Gene Patent Revoked in Europe
• UK Stem Cell Bank Officially Opens
• AAAS Supports Policy Push for Broader Access to New Human Embryonic Stem Cell Lines
• Appeals Ruling Could Impact Combination Drug Development
• Greater Access to Affordable Pharmaceuticals Act HR 1 Signed

Legislation

• Pharmaceutical Market Access and Drug Safety Act of 2004
• Stem Cell Research Enhancement Act of 2004

Hearings

Publications

• A Fair Deal for the Future: Flexibilities Under TRIPS
• Genes and Ingenuity: Gene Patenting and Human Health
• Has the Implementation of the TRIPS Agreement in Latin America and the Caribbean Produced Intellectual Property Legislation that Favours Public Health?
• Integrating Intellectual Property Rights and Development
• Ownership of knowledge - the role of patents in pharmaceutical R&D

Meetings

• 30 Nov 2006 8:30: Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge, and Folklore: Tenth Session
• 17 Nov 2005 14:00: Report Release and Public Briefing: IP Rights in Genomic and Proteomic Research
• 27 May 2005 8:30: Gene Patents and Public Health
• 21 Apr 2005 13:30: Bridging the Divide 2005 : Technology, Innovation and Learning in Developing Economies
• 11 Mar 2005 8:30: Biotechnology & Intellectual Property: Current Controversies
• 19 Feb 2005 13:00: AAAS Annual Meeting - Science & Intellectual Property Briefing
• 18 Feb 2005: Town Meeting on Patent System Reform
• 10 Jan 2005 8:00: Advancing Knowledge and the Knowledge Economy
• 25 Oct 2004 8:30: Global Challenges for Guiding and Managing Biological Technologies - meeting of the NAS Board on Agriculture and Natural Resources
• 20 Oct 2004 12:00: Gene Patenting and Human Health - Lunchtime Talk
• 4 Oct 2004: BIO IP Counsel Committee Meeting
• 18 Sep 2004: Patent Policy: Using, Abusing and Reforming
• 13 Sep 2004 8:30: Advisory Committee on Biotechnology and 21st Century Agriculture
• 8 Sep 2004 12:45: "Patents and Biotechnology: A U.S. Patent System for the 21st Century" Lunch talk
• 5 Aug 2004 8:00: National Academies: IP in Genomic and Protein Research and Innovation
• 16 Jul 2004: International Intellectual Property Law Conference
• 4 Jun 2004: Public Workshop: Intellectual Property Rights in Genomic and Protein-Related Inventions
• 12 Feb 2004: AAAS Annual Meeting